1 |
胡盛寿. 心力衰竭外科治疗现状与进展[J]. 中国循环杂志,2016,31(3): 209-213.
|
2 |
Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation[J]. Transpl Int, 2009,22(3): 269-278.
|
3 |
Malheiros SM, Almeida DR, Massaro AR, et al. Neurologic complications after heart transplantation[J]. Arq Neuropsiquiatr, 2002,60(2-A): 192-197.
|
4 |
黄洁. 心脏移植免疫抑制诱导和维持治疗[J/CD]. 中华移植杂志:电子版,2018,12(2): 49-54.
|
5 |
Miller LW. Cyclosporine-associated neurotoxicity. The need for a better guide for immunosuppressive therapy[J]. Circulation, 1996,94(6): 1209-1211.
|
6 |
Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review[J]. J Neurol, 1999,246(5): 339-346.
|
7 |
Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management[J]. Transpl Int, 2000,13(5): 313-326.
|
8 |
Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients[J]. Transplantation, 2000,69(4): 467-472.
|
9 |
Raja R, Johnston JK, Fitts JA, et al. Post-transplant seizures in infants with hypoplastic left heart syndrome[J]. Pediatr Neurol, 2003,28(5): 370-378.
|
10 |
Martin AB, Bricker JT, Fishman M, et al. Neurologic complications of heart transplantation in children[J]. J Heart Lung Transplant, 1992,11(5): 933-942.
|
11 |
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome[J]. N Engl J Med, 1996,334(8): 494-500.
|
12 |
Patchell RA. Neurological complications of organ transplantation[J]. Ann Neurol, 1994,36(5): 688-703.
|
13 |
Harirchian MH, Ghaffarpour M, Tabaeizadeh M, et al. Immunosuppressive drugs, an emerging cause of posterior reversible encephalopathy syndrome: case series[J]. J Stroke Cerebrovasc Dis, 2015,24(8): e191-e195.
|
14 |
Navarro V, Varnous S, Galanaud D, et al. Incidence and risk factors for seizures after heart transplantation[J]. J Neurol, 2010,257(4): 563-568.
|
15 |
Fitzgerald RT, Osorio J, Panigrahy A, et al. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome[J]. Pediatr Neurol, 2013,48(1): 76-78.
|
16 |
Dzudie A, Boissonnat P, Roussoulieres A, et al. Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?:case reports[J]. Transplant Proc, 2009,41(2): 716-720.
|
17 |
Sila CA. Spectrum of neurologic events following cardiac transplantation[J]. Stroke, 1989,20(11): 1586-1589.
|
18 |
Chabolla DR, Wszolek ZK. Pharmacologic management of seizures in organ transplant[J]. Neurology, 2006,67(12 Suppl 4): S34-S38.
|
19 |
Jarquin-Valdivia AA, Wijdicks EF, McGregor C. Neurologic complications following heart transplantation in the modern era: decreased incidence, but postoperative stroke remains prevalent[J]. Transplant Proc, 1999,31(5): 2161-2162.
|
20 |
Belvis R, Marti-Fàbregas J, Cocho D, et al. Cerebrovascular disease as a complication of cardiac transplantation[J]. Cerebrovasc Dis, 2005,19(4): 267-271.
|
21 |
Stockard JJ, Bickford RG, Schauble JF. Pressure-dependent cerebral ischemia during cardiopulmonary bypass[J]. Neurology, 1973,23(5): 521-529.
|
22 |
Chang SH, Lim CS, Low TS, et al. Cyclosporine-associated encephalopathy: a case report and literature review[J]. Transplant Proc, 2001,33(7-8): 3700-3701.
|
23 |
Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients[J]. Neurol Clin, 1988,6(2): 241-260.
|
24 |
Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management[J]. Transplantation, 1998,66(12): 1596-1604.
|
25 |
Selby R, Ramirez CB, Singh R, et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression[J]. Arch Surg, 1997,132(3): 304-310.
|
26 |
Penn I. Some problems with posttransplant lymphoproliferative disease[J]. Transplantation, 2000,69(5): 705-706.
|